Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALLO

Allogene Therapeutics Inc

Jun 10 • 04:00PM ET

1.78

-0.04 -2.20 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB IWN FESM SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	25.61%	Shs Outstand	345.15M	Perf Week	-11.00%
Market Cap	614.37M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.32%	Shs Float	256.74M	Perf Month	-21.93%
Enterprise Value	428.53M	PEG	-	EPS next Q	-0.17	Inst Own	39.01%	Short Float	17.32%	Perf Quarter	-32.32%
Income	-173.76M	P/S	-	EPS this Y	17.78%	Inst Trans	7.15%	Short Ratio	4.49	Perf Half Y	22.76%
Sales	0.00M	P/B	1.56	EPS next Y	-12.38%	ROA	-38.45%	Short Interest	44.48M	Perf YTD	29.93%
Book/sh	1.14	P/C	2.30	EPS next 5Y	6.15%	ROE	-52.32%	52W High	4.46 -60.09%	Perf Year	21.92%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 80.86%	Perf 3Y	-68.44%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.45% 6.94%	Perf 5Y	-93.09%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	34.11	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	-12.14%	Beta	0.49	Target Price	8.35
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-20.76%	Rel Volume	0.80	Prev Close	1.82
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	2.62%	Avg Volume	9.90M	Price	1.78
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	7,939,045	Change	-2.20%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)